World Pharma News - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
World Pharma News

World Pharma News

Publication
0 followers

Aggregates global press releases and news in pharma and biotech. Provides up-to-date announcements on drug discoveries, approvals, collaborations, and industry events.

Recent Posts

Merck to Complete Acquisition of Cidara Therapeutics
News•Jan 13, 2026

Merck to Complete Acquisition of Cidara Therapeutics

Merck completed its cash tender offer to acquire Cidara Therapeutics, paying $221.50 per share. The offer was accepted for 27.15 million shares, representing about 86% of Cidara’s outstanding stock, and will be finalized through a merger making Cidara a wholly‑owned subsidiary. The deal brings CD388, a long‑acting, strain‑agnostic antiviral, into Merck’s respiratory pipeline and is accounted for as an asset acquisition. Merck forecasts the transaction will increase 2026 R&D spend by roughly $9 billion and reduce GAAP and non‑GAAP EPS by about $0.30 in the first year.

By World Pharma News
One in Four Older Americans with Dementia Prescribed Risky Brain-Altering Drugs
News•Jan 12, 2026

One in Four Older Americans with Dementia Prescribed Risky Brain-Altering Drugs

A new JAMA study finds that about 25% of Medicare beneficiaries with dementia are prescribed potentially inappropriate CNS‑active medications that can cause falls, confusion, and hospitalizations. While overall prescribing of these drugs fell from 20% to 16% among all older...

By World Pharma News
Higher Consumption of Food Preservatives Is Associated with an Increased Risk of Type 2 Diabetes
News•Jan 9, 2026

Higher Consumption of Food Preservatives Is Associated with an Increased Risk of Type 2 Diabetes

Researchers from Inserm and partner institutions analyzed data from over 100,000 French adults in the NutriNet‑Santé cohort and found that higher consumption of food preservatives—both non‑antioxidant and antioxidant types—was linked to a 40‑49% increased incidence of type 2 diabetes. The study...

By World Pharma News
Blood Test Reveals Risk of Multimorbidity
News•Jan 8, 2026

Blood Test Reveals Risk of Multimorbidity

A study by Karolinska Institutet identified a handful of blood biomarkers that reliably predict multimorbidity risk in people over 60. Researchers measured 54 markers and found seven, especially five metabolic indicators, linked to disease count, patterns, and progression speed. The...

By World Pharma News
Bayer and Cradle Enter Collaboration to Enhance AI-Enabled Antibody Discovery and Optimization
News•Jan 7, 2026

Bayer and Cradle Enter Collaboration to Enhance AI-Enabled Antibody Discovery and Optimization

Pharma giant Bayer has signed a three‑year strategic collaboration with AI‑driven protein‑engineering firm Cradle to embed its generative platform into Bayer’s antibody R&D. The integration aims to accelerate lead generation, improve potency, safety and manufacturability, and reduce the number of...

By World Pharma News
Inhalable Therapy Aims for One-Two Punch Against Advanced Melanoma
News•Jan 6, 2026

Inhalable Therapy Aims for One-Two Punch Against Advanced Melanoma

Columbia engineers have created BEAT, an inhalable nanotherapy that uses engineered exosomes to co‑deliver PD‑1/PD‑L1 and Wnt/β‑catenin inhibitors directly to lung metastases of melanoma. In mouse models resistant to checkpoint inhibitors, inhaled BEAT achieved superior lung retention, dramatically suppressed tumor...

By World Pharma News
Machine Learning Drives Drug Repurposing for Neuroblastoma
News•Jan 5, 2026

Machine Learning Drives Drug Repurposing for Neuroblastoma

Researchers at Lund University used machine learning to repurpose existing drugs for high‑risk neuroblastoma. They identified a synergistic combination of a statin and a phenothiazine that markedly slowed tumor growth in mouse models. Laboratory trials showed reduced tumor cholesterol, increased...

By World Pharma News
New Technique Lights up Where Drugs Go in the Body, Cell by Cell
News•Jan 2, 2026

New Technique Lights up Where Drugs Go in the Body, Cell by Cell

Researchers at Scripps have unveiled vCATCH, a whole‑body imaging platform that lights up covalent drugs at single‑cell resolution in mice. By attaching a tiny chemical handle to drugs and using highly selective click‑chemistry, the method tags each bound molecule with...

By World Pharma News
Right Blood Pressure Drug Can Reduce Healthcare Costs
News•Dec 30, 2025

Right Blood Pressure Drug Can Reduce Healthcare Costs

Researchers analyzed over 340,000 Swedish hypertension patients and found that initiating treatment with angiotensin‑receptor blockers (ARBs) leads to markedly higher long‑term medication persistence. After five years, 80 % of ARB starters remained adherent, versus 65 % for calcium‑channel blockers, the next best...

By World Pharma News
The Natural Human Protein Drug May Halt Neuron Death in Alzheimer's Disease
News•Dec 29, 2025

The Natural Human Protein Drug May Halt Neuron Death in Alzheimer's Disease

University of Colorado researchers found that the FDA‑approved drug sargramostim, a synthetic GM‑CSF protein, reduced the blood biomarker UCH‑L1 of neuronal death by 40% in Alzheimer’s patients, bringing levels down to those seen in early life. The study also documented...

By World Pharma News
Groundbreaking Discovery Turns Household Plastic Recycling Into Anti-Cancer Medication
News•Dec 24, 2025

Groundbreaking Discovery Turns Household Plastic Recycling Into Anti-Cancer Medication

University of St Andrews researchers have demonstrated a ruthenium‑catalysed semi‑hydrogenation that depolymerises household PET waste into ethyl‑4‑hydroxymethyl benzoate (EHMB). EHMB is a versatile intermediate for high‑value drugs such as the cancer therapy Imatinib, as well as tranexamic acid and the...

By World Pharma News
Accelerated Cancer Drug Approvals Deliver Limited Survival Gains at High Cost
News•Dec 23, 2025

Accelerated Cancer Drug Approvals Deliver Limited Survival Gains at High Cost

A BMJ Medicine study examined Medicare’s use of FDA accelerated‑approval cancer drugs from 2012‑2020. Of the 178,000 beneficiaries treated, only 45% received drugs that later proved to extend survival, adding an estimated 76,000 life‑years. The three most beneficial drugs accounted...

By World Pharma News
Tiny Viral Switch Offers Hope Against Drug-Resistant Bacteria
News•Dec 22, 2025

Tiny Viral Switch Offers Hope Against Drug-Resistant Bacteria

Researchers at Hebrew University identified a tiny phage‑encoded RNA, PreS, that reprograms bacterial host cells during infection. PreS binds to the folded region of the bacterial dnaN mRNA, unfolding it and boosting production of the DnaN replication protein. The resulting...

By World Pharma News
NU-9 Halts Alzheimer's Disease in Animal Model Before Symptoms Begin
News•Dec 19, 2025

NU-9 Halts Alzheimer's Disease in Animal Model Before Symptoms Begin

Northwestern researchers report that the small‑molecule NU‑9 eliminates a newly identified toxic amyloid‑beta oligomer subtype in a pre‑symptomatic mouse model of Alzheimer’s disease. Daily oral administration for 60 days dramatically reduced reactive astrogliosis, neuroinflammation, and associated TDP‑43 pathology across multiple...

By World Pharma News
The Antibiotic Delafloxacin Emerges as a Potential Therapeutic Alternative Against Legionella
News•Dec 18, 2025

The Antibiotic Delafloxacin Emerges as a Potential Therapeutic Alternative Against Legionella

Researchers at the IGTP demonstrated that delafloxacin inhibits intracellular Legionella replication more effectively than levofloxacin in a macrophage model. The fluoroquinolone achieved bacterial killing at concentrations five to ten times lower than the current standard, except for L. longbeachae where...

By World Pharma News
Accelerating Drug Combination Discovery with Machine Learning
News•Dec 17, 2025

Accelerating Drug Combination Discovery with Machine Learning

St. Jude researchers unveiled Combocat, an open‑source platform that merges acoustic liquid handling with machine‑learning models to screen drug combinations at unprecedented scale. The system tested 9,045 drug pairs on a neuroblastoma cell line, identifying multiple synergistic hits that were...

By World Pharma News

Page 2 of 2

← Prev12